TARSA THERAPEUTICS
Tarsa Therapeutics is developing an oral formulation of calcitonin, a peptide hormone for the treatment of osteoporosis that slows the rate of bone destruction.
TARSA THERAPEUTICS
Industry:
Biotechnology Medical Medical Device
Founded:
2009-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.tarsatherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
267-273-7940
Total Funding:
124.25 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
NeurogesX
NeurogesX develops and commercializes therapies for chronic peripheral neuropathic pain.
Current Advisors List
Current Employees Featured
Founder
Investors List
Square 1 Bank
Square 1 Bank investment in Debt Financing - Tarsa Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Debt Financing - Tarsa Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Tarsa Therapeutics
Novo Holdings
Novo Holdings investment in Series B - Tarsa Therapeutics
Quaker Partners
Quaker Partners investment in Series B - Tarsa Therapeutics
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Tarsa Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Tarsa Therapeutics
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Tarsa Therapeutics
Marker
Marker investment in Series B - Tarsa Therapeutics
Quaker BioVentures
Quaker BioVentures investment in Series B - Tarsa Therapeutics
Official Site Inspections
http://www.tarsatherapeutics.com
- Host name: redirect-v225.secureserver.net
- IP address: 184.168.47.225
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260